RNA
USDAvidity Biosciences Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$69.780
Haut
$69.870
Bas
$69.760
Volume
7.06M
Fondamentaux de l'Entreprise
Capitalisation Boursière
10.3B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
5.20M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
TD Cowen Downgrades Avidity Biosciences to Hold, Lowers Price Target to $74
TD Cowen analyst Ritu Baral downgrades Avidity Biosciences from Buy to Hold and lowers the price target from $78 to $74.
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Chardan Capital Downgrades Avidity Biosciences to Neutral, Lowers Price Target to $72
Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences from Buy to Neutral and lowers the price target from $75 to $72.
RBC Capital Downgrades Avidity Biosciences to Sector Perform, Raises Price Target to $72
RBC Capital analyst Luca Issi downgrades Avidity Biosciences from Outperform to Sector Perform and raises the price target from $61 to $72.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avidity Biosciences, Inc. (NASDAQ: RNA)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Avidity Biosciences to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.